Slone Partners

A premier executive search and talent advisory firm delivering visionary leaders and fractional talent amazing life sciences and healthcare organizations

[Slone Partners @SlonePartners]

Slone Partners is proud to sponsor #PMC2026, bringing together hundreds of healthcare providers, physicians, researchers, & patient advocates advancing the future of personalized medicine. Planning to attend? Connect with our CEO Leslie Loveless at [email protected].

[Slone Partners @SlonePartners]

For #DiabetesAwarenessMonth, we recognize the scientists, clinicians, patients, and #LifeSciences companies advancing diabetes diagnosis, treatment, and prevention. Their efforts show how great science and strong leadership combine to improve lives.💙

[Slone Partners @SlonePartners]

For #DiabetesAwarenessMonth, we recognize the scientists, clinicians, patients, and #LifeSciences companies advancing diabetes diagnosis, treatment, and prevention. Their efforts show how great science and strong leadership combine to improve lives.💙

[Slone Partners @SlonePartners]

Today, Slone Partners celebrates 26 years. Thank you to our clients, candidates, and colleagues who have been part of our journey!

[Slone Partners @SlonePartners]

This #BreastCancerAwarenessMonth, we stand with patients, survivors, families & caregivers and salute the researchers, clinicians & advocates working to advance earlier detection, better treatments, & improved outcomes. #BreastCancerAwareness

[Slone Partners @SlonePartners]

What are the primary factors driving retirement decisions in biopharma? Our CEO|Managing Partner Leslie Loveless shares her thoughts in this article in @BioSpace. Among her insights–many delay retirement because they want to continue making an impact. https://t.co/yJyjdL2dOK

[Slone Partners @SlonePartners]

Today, we remember September 11, 2001.

Twenty-five years later, we honor the lives lost, the families forever changed, and the courage of the first responders and countless individuals who stepped forward in the face of unimaginable tragedy.

#NeverForget #September11

[Slone Partners @SlonePartners]

This month, we raise awareness, challenge stigmas, & support the millions affected by Alzheimer’s, including their families & caregivers. We also recognize the researchers, clinicians, scientists, & leaders advancing new diagnoses, treatments, & improving quality of life.

[Slone Partners @SlonePartners]

Slone Partners delivers visionary leaders and fractional talent for dynamic organizations in life sciences and healthcare. Learn more at https://t.co/RVId9LE1uw

[Slone Partners @SlonePartners]

Slone Partners is proud to announce the placement of Farhad Ghavami as Chief Executive Officer at @SeqCenter !

Read the full press release here: https://t.co/TA3wHOeHu0

[Slone Partners @SlonePartners]

We are proud to announce the appointments of Sona Stroud M.Ed. and Kim Wilson as Senior Partners at Slone Partners. 🎉
Read the full announcement: https://t.co/qVc3iKlr8X

[Slone Partners @SlonePartners]

Dynamic #Healthcare organizations driving innovation need visionary leaders with determination, ethics, & heart. We align with your needs to deliver transformative talent who push the boundaries of possibility. Learn more about how we can work together: https://t.co/sCJdFGjaS6

[Slone Partners @SlonePartners]

Slone Partners is pleased to announce the placement of Amer Mirza, PhD, as Chief Scientific Officer (CSO) at Prolynx.

Read the full press release here: https://t.co/YxIUwQwKfb

[Slone Partners @SlonePartners]

De-risking the executive recruiting & hiring process requires an intentional & strategic approach that defines the success profile, produces a broad candidate pool, & allows for structured integration. Read more in our new blog.
https://t.co/MZ9Ugrj6kX

[Slone Partners @SlonePartners]

It’s fascinating to track the rapid advances in precision medicine as it redefines healthcare by moving beyond one-size-fits-all treatments to therapies specifically tailored to each patient's unique genetic, environmental, & lifestyle profile. https://t.co/t0AzGCfwnw

[Slone Partners @SlonePartners]

Great news! June saw a surge of investment activity, boosting the number of $100M raises to 40 for the first half of the year. Stronger financing reflects renewed confidence in companies working across a range of therapeutic areas. https://t.co/osxp6wN5xE

[Slone Partners @SlonePartners]

In today’s unpredictable business climate, companies need flexibility to stay competitive. Our Fractional Talent service provides you access to proven leaders & functional specialists to fill part-time, interim, or project-based roles. Learn more: https://t.co/YFsL6XqKHi

[Slone Partners @SlonePartners]

The life sciences IPO market continues to show signs of recovery. As the @BosBizJournal reports, a growing number of Massachusetts biotech companies are successfully entering the public markets – a positive signal for investor confidence. https://t.co/2zxuB5cdI7

[Slone Partners @SlonePartners]

The convergence of machine learning, precision medicine, & pharmacogenomics is opening an exciting new chapter in healthcare by helping researchers better understand how an individual’s genetic makeup influences their response to different therapies. https://t.co/GNT3SMKdFu

[Slone Partners @SlonePartners]

You want visionary leaders who push the boundaries of possibilities in a dynamic industry, so you turn to us for our industry knowledge, extensive talent network, & extraordinary track record. Learn how we can be your complete search partner: https://t.co/ZL6mrxHGQH